| 2024-06-17 | Sale | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 372 0.0009% | $1.26 | $470 | -11.28% | |
| 2024-04-04 | Sale | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 1,069 0.0031% | $2.63 | $2,817 | -22.12% | |
| 2023-05-15 | Sale | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 5,000 0.0174% | $27.17 | $135,864 | -87.99% | |
| 2023-03-15 | Sale | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 2,084 0.0072% | $19.50 | $40,638 | -79.74% | |
| 2021-02-01 | Sale | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 7,500 0.0159% | $26.85 | $201,375 | -40.89% | |
| 2018-12-03 | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 1,000 0.007% | $5.20 | $5,200 | +79.76% | ||
| 2018-11-30 | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 1,000 0.0071% | $5.00 | $5,000 | +89.65% | ||
| 2018-11-29 | BioXcel Therapeutics, Inc. BTAI | Chief Financial Officer | 1,000 0.0073% | $5.00 | $5,000 | +93.45% | ||
| 2016-04-14 | Actinium Pharmaceuticals, Inc. ATNM | director | 5,000 0.0108% | $2.01 | $10,050 | -25.37% | ||
| 2013-06-25 | STRATA Skin Sciences, Inc. SSKN | Chief Financial Officer | 3,000 0.007% | $0.81 | $2,427 | -14.34% | ||
| 2010-08-12 | STRATA Skin Sciences, Inc. SSKN | Chief Financial Officer | 1,000 0.004% | $6.32 | $6,320 | -49.61% |